Drug
L Alanyl L Glutamine
L Alanyl L Glutamine: highest development phase Phase 3, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| L-Alanyl/L-Glutamine NCT04019184 | Phase 3 | Cardiac Surgery |
Latest
No recent events.
Follow L Alanyl L Glutamine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.